Skip to main content
Equibles

WINDLAS · Windlas Biotech Limited

Use WINDLAS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WINDLAS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,001.45 INR -11.75 (-1.16%) At close · Nov 13
Rebalance outlook locked
Market Cap
20.67B INR
Shares
20.64M
Volume · Nov 13 70.29K Avg daily vol (3M) 148.05K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close1,001.45 INR Open1,008.40 INR Day994.00–1,030.95 INR 52W close705.75–1,154.75 INR Avg vol 30d132K Last earningsNov 6, 2026 DataAug 2021–Nov 2026

Latest documents

2026
Nov 6
Earnings call
Revenue crosses INR500 crores as CDMO grows 34%

Windlas Biotech Limited reported H1 FY27 revenue of INR512 crores, up 18%, with Q2 revenue rising 19% to INR264 crores. CDMO revenue grew 34% to INR215 crores, while Plant 6 began commercialization in September 2026.

4 source passages
Ladies and gentlemen, good day and welcome to the Q2 and H1 FY27 Earnings Conference Call for Windlas Biotech Limited. In H1 FY27, Windlas crossed INR500 crores milestone in half-yearly revenue for the first time. Revenue grew 19% y-o-y to INR264 crores in Q2, and 18% to INR512 crores in H1 of FY27. Generic formulation CDMO remains our anchor. Customers have entrusted us with a larger share of their portfolios and new products, which lifted Q2 FY27 revenue by 34% to INR215 crores, and H1 FY27 revenue by 32% to INR422 crores. In line with our long-term growth aspirations, the commercialization of Plant 6 in September 2026 marks a key addition to our manufacturing infrastructure. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲20.2% 1.95B INR 152.27M INR '25 Q3 ▲18.3% 2.03B INR 162.85M INR '25 Q4 ▲19.9% 2.10B INR 176.65M INR '26 Q1 ▲18.9% 2.22B INR 178.00M INR '26 Q2 ▲19.5% 2.33B INR 149.54M INR '26 Q3 ▲17.7% 2.38B INR 160.16M INR '26 Q4 ▲18.1% 2.48B INR 176.53M INR '27 Q1 LATEST ▲18.7% 2.64B INR 180.52M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 705.75 INR Now 1,001.45 INR · 66% Range high 1,154.75 INR
vs 200-day avg +14% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:WINDLAS +0.7% +8.4% +26.8% +14.3% +26.0%

Exchange listing

Market
XNSE
Ticker
WINDLAS
ISIN
INE0H5O01029
Security
Ordinary share
Trading currency
INR

Company

Website
https://windlas.com/
Investor relations
https://windlas.com/schedule-of-analyst/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-07-16 6.30 INR
2025-07-21 5.80 INR
2024-09-17 5.50 INR
2023-09-05 4.00 INR
2022-09-09 3.50 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-06 Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-11 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-22 Transcript
    Earnings Call for the Quarter Ended March 31, 2026